171 related articles for article (PubMed ID: 2593286)
21. Diphosphonates in the evaluation of metabolic bone disease.
Fogelman I; Smith ML
Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
[TBL] [Abstract][Full Text] [Related]
22. [Differential diagnosis of osteomalacia and other forms of renal osteodystrophy in terminal renal failure by dynamic scintigraphy with diphosphonate].
Novikov AI; Ermolenko AE; Ermakova IP; Baeva LB; Levitskiĭ ER
Ter Arkh; 1989; 61(6):105-9. PubMed ID: 2799693
[TBL] [Abstract][Full Text] [Related]
23. [Metabolic bone diseases (4): Renal osteodystrophy].
Seto H
Rinsho Hoshasen; 1987 May; 32(5):619-20. PubMed ID: 3613202
[No Abstract] [Full Text] [Related]
24. Value of the 99mTc-methylene diphosphonate bone scan in renal osteodystrophy.
Karsenty G; Vigneron N; Jorgetti V; Fauchet M; Zingraff J; Drüeke T; Cournot-Witmer G
Kidney Int; 1986 May; 29(5):1058-65. PubMed ID: 3723927
[TBL] [Abstract][Full Text] [Related]
25. Changing manifestations of brown tumors on bone scan in renal osteodystrophy.
Brown WT; Lyons KP; Winer RL
J Nucl Med; 1978 Oct; 19(10):1146-8. PubMed ID: 722326
[TBL] [Abstract][Full Text] [Related]
26. The diagnosis of renal osteodystrophy: a comparison of Technetium-99m-pyrophosphate bone scintigraphy with other techniques.
Hodson EM; Howman-Giles RB; Evans RA; Bautovich G; Hills EE; Sherbon K; Bach BD; Horvath JS; Tiller DJ
Clin Nephrol; 1981 Jul; 16(1):24-8. PubMed ID: 6268343
[TBL] [Abstract][Full Text] [Related]
27. Scintigraphic skeletal changes in non-dialyzed patients with advanced renal failure.
Olgaard K; Madsen S; Heerfordt J; Hammer M; Jensen H
Clin Nephrol; 1979 Dec; 12(6):273-8. PubMed ID: 527281
[TBL] [Abstract][Full Text] [Related]
28. Bone scan evidence of renal osteodystrophy in undialyzed uremic patients.
Smith AJ; Sy W; Lao R
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():130-6. PubMed ID: 756035
[TBL] [Abstract][Full Text] [Related]
29. A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients.
Kurata S; Ishibashi M; Nishida H; Hiromatsu Y; Hayabuchi N
Ann Nucl Med; 2004 Sep; 18(6):513-8. PubMed ID: 15515752
[TBL] [Abstract][Full Text] [Related]
30. Radiophosphate disclosure of subperiosteal bone formation in renal osteodystrophy.
Rosenthall L; Rush C
J Nucl Med; 1986 Oct; 27(10):1572-6. PubMed ID: 3760982
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of 99mTc pyrophosphate bone scintigraphy in the survey of dialysis osteodystrophy.
Vanherweghem JL; Schoutens A; Bergman P; Dhaene M; Goldman M; Fuss M; Kinnaert P
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():431-4. PubMed ID: 2986102
[TBL] [Abstract][Full Text] [Related]
32. [Histological and scintigraphic correlations in the diagnosis of uremic osteodystrophy].
Neumair F; Huber W; Riegler P; Cabassa N
Radiol Med; 1980 Oct; 66(10):762-3. PubMed ID: 6452655
[No Abstract] [Full Text] [Related]
33. [Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy].
Dudczak R; Kletter K; Czembirek H; Derfler K; Marosi L; Salomonowitz E; Schmidt P; Wurzer G; Zazgornik J
Wien Klin Wochenschr; 1984 Apr; 96(9):326-32. PubMed ID: 6236616
[TBL] [Abstract][Full Text] [Related]
34. Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.
de Graaf P; Pauwels EK; Vos PH; Schicht IM; te Velde J; de Graeff J
Eur J Nucl Med; 1984; 9(9):419-25. PubMed ID: 6437823
[TBL] [Abstract][Full Text] [Related]
35. [Classification of bone scintigrams in hemodialysis patients].
Ishibashi K; Miyamae T
Kaku Igaku; 1985 Mar; 22(3):367-76. PubMed ID: 3160875
[No Abstract] [Full Text] [Related]
36. Tracer accumulation in femoral head during early phase of bone scintigraphy after renal transplantation.
Kubota T; Ushijima Y; Okuyama C; Kubo T; Nishimura T
J Nucl Med; 2001 Dec; 42(12):1789-94. PubMed ID: 11752074
[TBL] [Abstract][Full Text] [Related]
37. Effects of renal failure and metabolic diseases upon bone scanning in children.
Schümichen C
Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
[No Abstract] [Full Text] [Related]
38. Usefulness of whole PTH assay in patients with renal osteodystrophy--correlation with bone scintigraphy.
Kaida H; Ishibashi M; Nishida H; Baba K; Hiromatsu Y; Okuda S; Hayabuchi N
Ann Nucl Med; 2005 May; 19(3):179-84. PubMed ID: 15981669
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of renal-skeleton ratio of technetium-99m phosphonate in multiple myeloma.
Dey HM; Karimeddini MK; Spencer RP; Sziklas JJ
J Nucl Med; 1985 Nov; 26(11):1270-4. PubMed ID: 4056922
[TBL] [Abstract][Full Text] [Related]
40. Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hyperparathyroidism as the major cause.
de Graaf P; te Velde J; Pauwels EK; Schicht IM; Kleiverda K; de Graeff J
Eur J Nucl Med; 1982; 7(4):152-4. PubMed ID: 7075618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
